Israeli venture investor OurCrowd has launched a new $50 million fund, and it’s the first to be focused exclusively on medtech and healthcare delivery.
Read more here.
Israeli venture investor OurCrowd has launched a new $50 million fund, and it’s the first to be focused exclusively on medtech and healthcare delivery.
Read more here.